Carlos Cordon-Cardo

Affiliations: 
Genetics and Development Columbia University, New York, NY 
Area:
Genetics, Human Development
Google:
"Carlos Cordon-Cardo"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang YA, Sfakianos J, Tewari AK, et al. (2020) Molecular tracing of prostate cancer lethality. Oncogene
Lunardi A, Ala U, Epping MT, et al. (2020) Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics
Carver BS, Tran J, Gopalan A, et al. (2020) Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature Genetics
Han D, Rodriguez-Bravo V, Izadmehr S, et al. (2019) Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts. Journal of Visualized Experiments : Jove
Guarnerio J, Zhang Y, Cheloni G, et al. (2019) Intragenic antagonistic roles of protein and circRNA in tumorigenesis. Cell Research
Bodo S, Campagne C, Thin TH, et al. (2018) Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury. The Journal of Clinical Investigation
Chen M, Zhang J, Berger AH, et al. (2018) Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis. The Journal of Clinical Investigation
Smith JT, Wunsch BH, Dogra N, et al. (2018) Integrated nanoscale deterministic lateral displacement arrays for separation of extracellular vesicles from clinically-relevant volumes of biological samples. Lab On a Chip
Wang L, Saci A, Szabo PM, et al. (2018) EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications. 9: 3503
Donovan MJ, Fernandez G, Scott R, et al. (2018) Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test. Prostate Cancer and Prostatic Diseases
See more...